Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
Company Details
- Employees
- 24
- Founded
- -
- Address
- South San Francisco, Ca 94080, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://linkcelltx.com/
- Keywords
- Engineer jobs.
- HQ
- South San Francisco, CA
Link Cell Therapies Questions
Link Cell Therapies's website is https://linkcelltx.com/
Link Cell Therapies's LinkedIn profile is https://www.linkedin.com/company/linkcelltx
Link Cell Therapies has
24 employees.
View email and phone details for 24
employees at Link Cell Therapies.
Link Cell Therapies's industry is
Biotechnology Research
Link Cell Therapies's top competitors are
Arsenal Biosciences, Inc.,
Graphite Bio,
Arda Therapeutics,
Xaira Therapeutics,
Cartography Biosciences,
Cargo Therapeutics,
Lyell Immunopharma,
Cellink,
Allogene Therapeutics,
Sastra Cell Therapy.
Link Cell Therapies's categories are Biotechnology Research
Link Cell Therapies's founding year is 2022
